Zobrazeno 1 - 10
of 26
pro vyhledávání: '"R. M. Fazlyeva"'
Publikováno v:
Журнал инфектологии, Vol 10, Iss 4, Pp 48-52 (2018)
Purpose: to estimate the content of platelets and sP-selectin in patients with different severity of Hemorrhagic Fever with Renal Syndrome. Materials and methods: we have conducted the clinical and laboratory examination of 220 patients with Hemorrha
Externí odkaz:
https://doaj.org/article/4dc74e9d865d41fda1da66cdacdc02fd
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 58-63 (2017)
The relevance of effective therapy of community-acquired pneumonia (CAP) with a view to improving the prognosis in severe and complicated course of the disease requires a reasonable correction. In this paper, based on the results of earlier clinicali
Externí odkaz:
https://doaj.org/article/f8d4ed4b5bdb48fca137b5ca527b9818
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 1, Iss 1, Pp 8-12 (2016)
Background: Obesity is characterized by an increased risk of diabetes mellitus, coronary heart disease, arterial hypertension and reproductive system disorders, which makes it necessary to implement multifactorial correction of metabolic disturbances
Externí odkaz:
https://doaj.org/article/7bf0db5086b740c39dd548f26fcd4453
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 68-73 (2015)
The article analyzes the immunomodulatory therapy as part of pathogenetic treatment of community-acquired pneumonia. Immunological monitoring of patients with severe community-acquired pneumonia demonstrated a disbalance of natural resistance factors
Externí odkaz:
https://doaj.org/article/b9c1bfe951ce4d4cb8ca3acaf22f2ddb
Publikováno v:
Медицинская иммунология, Vol 11, Iss 1, Pp 57-62 (2014)
Abstract. A study was carried out in hundred-five patients with severe or mid-severe clinical courseof community-acquired pneumonia. Clinical observations showed that introduction of Imunofan andPolyoxidonium within combined therapeutic regimen admin
Externí odkaz:
https://doaj.org/article/0b95757e18124d97a8fecf549c4cabcb
Publikováno v:
Медицинская иммунология, Vol 9, Iss 6, Pp 605-612 (2014)
Abstract. Clinical and immunological examination was performed in a group of 120 patients with community-acquired pneumonia. The study included determination of humoral and cellular immunity factors, T-lymphocytes, T cell subpopulations and B cells i
Externí odkaz:
https://doaj.org/article/b6adfbb9e51a4b5ea9cbf8a6514d337a
Autor:
G. A. Galieva, G. Kh. Mirsaeva, R. M. Fazlyeva, E. R. Kamaeva, O. L. Andrianova, D. I. Masalimova, A. Kh. Islamgulov, V. V. Nikulina, A. R. Imaeva
Publikováno v:
Meditsinskiy sovet = Medical Council. :44-50
Introduction. The study of myocardial damage in COVID-19 and hemorrhagic fever with renal syndrome (HFRS) is relevant, especially for HFRS-endemic regions. Aim. Comparative study of clinical and electrocardiographic signs of myocardial damage in HFRS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5524e1ea1637d8c5b5089cc5948f7cb
https://doi.org/10.21518/ms2023-055
https://doi.org/10.21518/ms2023-055
Autor:
G. A. Mukhetdinova, R. M. Fazlyeva, A. A. Talkhina, G. Kh. Mirsaeva, G. D. Boris, E. R. Kamaeva
Publikováno v:
Practical medicine. 17:94-98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abf38b3a9ecdaafc848eacd2c6e5df2b
https://doi.org/10.32000/2072-1757-2019-2-94-98
https://doi.org/10.32000/2072-1757-2019-2-94-98
Publikováno v:
Žurnal Infektologii, Vol 10, Iss 4, Pp 48-52 (2018)
Purpose: to estimate the content of platelets and sP-selectin in patients with different severity of Hemorrhagic Feverwith Renal Syndrome. Materials and methods: we have conducted the clinical and laboratory examination of 220 patients with Hemorrhag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6197cb239817fe8a7027bf8e34035228
https://doi.org/10.22625/2072-6732-2018-10-4-48-52
https://doi.org/10.22625/2072-6732-2018-10-4-48-52
Autor:
R. M. Fazlyeva, Human Wellbeing, Moscow, Russian Federation, A.V. Tutelyan, O.G. Stepanov, G. Kh. Mirsaeva, G. A. Mukhetdinova, G. M. Khasanova, L.A. Ibragimova
Publikováno v:
Infekcionnye bolezni. 16:48-54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a560513037477a8d36ee9794c603eb1
https://doi.org/10.20953/1729-9225-2018-4-48-54
https://doi.org/10.20953/1729-9225-2018-4-48-54